Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

Lerma, F. Álvarez; Zambrano, Carmen; Vidal, F. Gordo; Suarez, C. Ruano; Pallás, T. Aldabó; Garnacho-Montero, José; Navarro, Raquel; Suarez, María Carmen Ruano; Araujo, Inmaculada Alonso; Seisdedos, Ángel Arenzana; López, Alberto Córdoba; Redondo, Nuria Camino; Ansorregui, Sandra Barbadillo; Fernández, Lorena; Otero, Maria Elena Vilas; Alonso, José Antonio Márquez; Blázquez, Adoración Gema Bueno; Álvarez, A.; Palanco, Joaquín Lobo; Castañeda, Luis; García, Miguel Ángel; Núñez, Maria Dolores; Soto, María Teresa Tebar; Avión, Rafael Cabadas; Costa, Ricardo; García, José Ángel Berezo; López, Fernando García; Matamala, B. López; A, Ferra; García, María Sopetrán Rey; Calderón, Belén Cidoncha; Carmona, Sara Alcántara; Riestra, Eva Manteiga; Rueda, Bernardo Gil; González, Carlos Gallego; Sánchez, Roberto Jiménez; Martín-Consuegra, Ismael López de Toro; Higueras, Jessica Souto; Azcona, A. Lander; Lozano, José Maria; Vera-Artázcoz, Paula; Orjales, María José Castro; Marcide, H. Arquitecto; Foncea, M. A. Estecha; Valero, Roberto Reig; Sanz, Jesús Priego; Daunis, J. Vallés; Galindo, Ana Isabel Ezpeleta; B, Martinez; Lamo, Felipe Bobillo de; Ribas, Antoni Margarit; Astigarraga, P.M. Olaechea; Herráez, Juan Carlos Ballesteros; Fernández, María Teresa Saldaña; Miralles, Ángel Sánchez; Villar, Rosario Amaya; López-Cuervo, Juan Fajardo; Socías, Antònia; Saris, A; Lamas, A.; Amiano, José Ramón Iruretagoyena; Rivera, Isabel Sánchez Afán de; García, María Cerón; González, Susana Moradillo; Pedreira, Paula Rodríguez; Herrejón, E. Palencia; Núñez, Carlos López; Lodo, Margarita Mas; Talavera, J. C. Pardo; Mora, María L.; Ferrer, Ricard; Óconnor, Eugenia de La Fuente; García, Miguel Sánchez; Huelga, Carmen Blanco; Catalina, María; López, Adoración Alcalá; Gutierrez, Marta Ugalde; Ruiz, María Rosa Navarro; Millan, María José Román; Aguayo, Pedro Lara; Gonzalo, M Herreros; Cabrera, Laura Claverias; López, José Martos; Mahave, M.; López, Daniel Fontaneda; Martínez, María Matachana; Sánchez, Esther; Lluch, Carmen Santarrufina; González, Rafael Garcés; Lara, Sonia Gallego; Trivez, Pilar Martinez; Pàmies, Cecília Vilanova; Jorge, Celina Llanos; Martín, María Luisa Martínez; García-Arriaza, Juan; Pardavila, Enrique Alemparte

doi:10.1016/j.medine.2021.05.003

Cited by 1 publication

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Spain, it is estimated that 15% of patients admitted to Intensive Care Units suffer from cancer, according to data from the ENVIN-HELICS study [ 3 ].…”

Section: Part One - Dimension Of the Problem In Solid Organ Tumorsmentioning

confidence: 99%

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

Bouza

Martı́n²,

Alés³

et al. 2022

Rev Esp Quimioter

View full text Add to dashboard Cite

We do not know the precise figure for solid organ tumors diagnosed each year in Spain and it is therefore difficult to calculate whether there has been a decrease in cancer diagnoses as a consequence of the pandemic. Some indirect data suggest that the pandemic has worsened the stage at which some non-hematological neoplasms are diagnosed. Despite the lack of robust evidence, oncology patients seem more likely to have a poor outcome when they contract COVID-19. The antibody response to infection in cancer patients will be fundamentally conditioned by the type of neoplasia present, the treatment received and the time of its administration. In patients with hematological malignancies, the incidence of infection is probably similar or lower than in the general population, due to the better protective measures adopted by the patients and their environment. The severity and mortality of COVID-19 in patients with hematologic malignancies is clearly higher than the general population. Since the immune response to vaccination in hematologic patients is generally worse than in comparable populations, alternative methods of prevention must be established in these patients, as well as actions for earlier diagnosis and treatment. Campaigns for the early diagnosis of malignant neoplasms must be urgently resumed, post-COVID manifestations should be monitored, collaboration with patient associations is indisputable and it is urgent to draw the right conclusions to improve our preparedness to fight against possible future catastrophes.

show abstract

“…In Spain, it is estimated that 15% of patients admitted to Intensive Care Units suffer from cancer, according to data from the ENVIN-HELICS study [ 3 ].…”

Section: Part One - Dimension Of the Problem In Solid Organ Tumorsmentioning

confidence: 99%

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

Bouza

Martı́n²,

Alés³

et al. 2022

Rev Esp Quimioter

View full text Add to dashboard Cite

show abstract

Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

Cited by 1 publication

References 29 publications

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

Contact Info

Product

Resources

About